Source:http://linkedlifedata.com/resource/pubmed/id/12402342
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
2002-10-28
|
pubmed:abstractText |
The LDL receptor-related protein/alpha 2-macroglobulin receptor (LRP1/A2MR) is a multifunctional cell-surface glycoprotein that endocytoses several structurally and functionally distinct ligands. In clinical studies different genomic variants of the LRP1/A2MR and its role in the development of degenerative diseases like atherosclerosis or Alzheimer's disease were studied. We screened for novel genomic variants of LRP1/A2MR and investigated the importance of these variants in 214 coronary patients suffering from myocardial infarction as well as in 224 healthy controls. We detected a novel C>G polymorphism at position -25 in the functionally important promoter region of LRP1/A2MR. This polymorphism (c.1-25C>G) leads to the creation of a new GC-box, recognized by the constitutively expressed SP 1 transcription factor. Investigating the LRP1/A2MR gene expression with respect to this polymorphism, carriers of the mutant G-allele were found to have a higher mRNA expression level. A novel polymorphism in exon 22 (c.4012C>T), and two novel polymorphisms in intron 24 (IVS24+123C>A and IVS24+690G>A) associated with a previously described polymorphism in exon 61 (c.10249G>A), were related to the development of myocardial infarction. Two novel rare genetic variants of exon 88 (c.13933C>T) and intron 88 (IVS88+15G>A) were identified in four patients with severe coronary symptoms. However, the LRP1/A2MR gene expression was found to be independent of all identified novel genomic variants as well as other previously described changes (A217V, A775P, D2080N, D2632E, G4379S) except the promoter polymorphism.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
1098-1004
|
pubmed:author | |
pubmed:copyrightInfo |
Copyright 2002 Wiley-Liss, Inc.
|
pubmed:issnType |
Electronic
|
pubmed:volume |
20
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
404
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:12402342-Adult,
pubmed-meshheading:12402342-Coronary Artery Disease,
pubmed-meshheading:12402342-Female,
pubmed-meshheading:12402342-Genetic Predisposition to Disease,
pubmed-meshheading:12402342-Genetic Variation,
pubmed-meshheading:12402342-Genome, Human,
pubmed-meshheading:12402342-Humans,
pubmed-meshheading:12402342-Low Density Lipoprotein Receptor-Related Protein-1,
pubmed-meshheading:12402342-Male,
pubmed-meshheading:12402342-Monocytes,
pubmed-meshheading:12402342-Myocardial Infarction,
pubmed-meshheading:12402342-Polymorphism, Genetic,
pubmed-meshheading:12402342-Promoter Regions, Genetic,
pubmed-meshheading:12402342-RNA, Messenger
|
pubmed:year |
2002
|
pubmed:articleTitle |
The LDL receptor-related protein (LRP1/A2MR) and coronary atherosclerosis--novel genomic variants and functional consequences.
|
pubmed:affiliation |
Institute of Human Genetics and Medical Biology, University of Halle, Halle, Germany.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|